Anti-PINK1 (phospho T257) antibody [MJF-R36B-BCC-50],Abcam,AB303532

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Collaborations This antibody was developed with support from The Michael J. Fox Foundation.

Host

Rabbit

Reactivity

Human

Application

WB

Platform ID

BAB249090937

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-PINK1 (phospho T257) antibody [MJF-R36B-BCC-50]
Cat. No.AB303532
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationWB
ClonalityMonoclonal
Clone NumberMJF-R36B-BCC-50
Concentration0.527 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Serine/threonine-protein kinase which acts as a sensor of mitochondrial damage and protects against mitochondrial dysfunction during cellular stress. It phosphorylates mitochondrial proteins to coordinate mitochondrial quality control mechanisms that remove and replace dysfunctional mitochondrial components (PubMed : 14607334, PubMed : 15087508, PubMed : 18443288, PubMed : 18957282, PubMed : 19229105, PubMed : 19966284, PubMed : 20404107, PubMed : 20547144, PubMed : 20798600, PubMed : 22396657, PubMed : 23620051, PubMed : 23754282, PubMed : 23933751, PubMed : 24660806, PubMed : 24751536, PubMed : 24784582, PubMed : 24896179, PubMed : 24898855, PubMed : 25527291, PubMed : 32484300). Depending on the severity of mitochondrial damage, activity ranges from preventing apoptosis and stimulating mitochondrial biogenesis to eliminating severely damaged mitochondria via PINK1-PRKN-dependent mitophagy (PubMed : 14607334, PubMed : 15087508, PubMed : 18443288, PubMed : 19966284, PubMed : 20404107, PubMed : 20798600, PubMed : 22396657, PubMed : 23620051, PubMed : 23933751, PubMed : 24898855, PubMed : 32047033, PubMed : 32484300). When cellular stress results in irreversible mitochondrial damage, PINK1 accumulates at the outer mitochondrial membrane (OMM) where it phosphorylates pre-existing polyubiquitin chains at 'Ser-65', recruits PRKN from the cytosol to the OMM and activates PRKN by phosphorylation at 'Ser-65'; activated PRKN then ubiquinates VDAC1 and other OMM proteins to initiate mitophagy (PubMed : 14607334, PubMed : 15087508, PubMed : 19966284, PubMed : 20404107, PubMed : 20798600, PubMed : 23754282, PubMed : 23933751, PubMed : 24660806, PubMed : 24751536, PubMed : 24784582, PubMed : 25474007, PubMed : 25527291, PubMed : 32047033). The PINK1-PRKN pathway also promotes fission of damaged mitochondria through phosphorylation and PRKN-dependent degradation of mitochondrial proteins involved in fission such as MFN2 (PubMed : 18443288, PubMed : 23620051, PubMed : 24898855). This prevents the refusion of unhealthy mitochondria with the mitochondrial network or initiates mitochondrial fragmentation facilitating their later engulfment by autophagosomes (PubMed : 18443288, PubMed : 23620051). Also promotes mitochondrial fission independently of PRKN and ATG7-mediated mitophagy, via the phosphorylation and activation of DNM1L (PubMed : 18443288, PubMed : 32484300). Regulates motility of damaged mitochondria by promoting the ubiquitination and subsequent degradation of MIRO1 and MIRO2; in motor neurons, this likely inhibits mitochondrial intracellular anterograde transport along the axons which probably increases the chance of the mitochondria undergoing mitophagy in the soma (PubMed : 22396657). Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity). Phosphorylates LETM1, positively regulating its mitochondrial calcium transport activity (PubMed : 29123128). See full target information PINK1 phospho T257

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.